Flagship Ventures provides $25 mln to Rubius Therapeutics
Cambridge, Massachusetts-based Rubius Therapeutics, a functionalized red blood cells developer focused on treating autoimmune conditions, metabolic diseases, cancer and other serious diseases, has launched with $25 million in funding. Flagship Ventures was the investor.
9 December 2015•4 mins read
